Jane Street »

Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Jane Street

Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Jane Street from 13F filings

Historical chart of Jane Street investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Jane Street consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Jane Street

Quarter filed Position value Share count Share price at filing
2023-12-31 $9.0M 9.4M 0.95
2023-09-30 $6.8M 7.3M 0.93

More positions owned by Jane Street

Spdr S&p 500 Etf Tr option Put Option
Spdr S&p 500 Etf Tr option Call Option
Powershares Qqq Etf Put Opt 01/19 154.0 put Put Option
Tesla Motors Inc cmn Call Option
Tesla Motors Inc cmn Put Option
Ishares Tr Index option Put Option
Powershares Qqq Trust Call Option
Nvidia Corp option Put Option
Amazon Com Inc option Put Option
Nvidia Corp option Call Option
Apple Inc option Call Option
Apple Inc option Put Option
Facebook Inc call Call Option
Ishares Tr option Call Option
Spdr S&p 500 Etf Tr Tr Unit (SPY)

View all positions for Jane Street

Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1

Ubs Global Asset Management Americas
Readystate Asset Management
Steelhead Partners
Calamos Advisors
Aequim Alternative Investments
Davidson Kempner Capital Management
Wolverine Asset Management
Lazard Asset Management
Zazove Associates
Shenkman Capital Management
CNH Partners
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Capstone Investment Advisors
Citadel Advisors
MacKay Shields

View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1